$Ionis Pharmaceuticals (IONS.US)$Revenue soared to a high of...
$Ionis Pharmaceuticals (IONS.US)$Revenue soared to a high of $1,123 million in 2019, from 510 million to 810 million over the past five years, with an average growth rate of 18%. Operating profit was lost except in 2019. Net profit was both profitable in 2018 and 2019 due to income tax rebates, and losses for the remaining 3 years.
Revenue for the first three quarters of 2022 increased by 18%, operating profit and net profit losses both decreased by 14%, but losses remained.
I don't see much value in the investment right now.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
